MDBpartners

Location: Newtown, PA
Website: http://www.mdbpartners.com

Joined Mar 18, 2009

Bio: Founder of life sciences strategic advisory and management consulting firm MD Becker Partners LLC

MDBpartners
Blood Disease Drug Dacogen Gets Thumbs Down For Cancer Use | Biotech/pharma | http://t.co/MzGhxVla http://t.co/uRC66izi $ASTX $CYCC $CELG

Feb. 9 at 3:11 PM

from Twitter
MDBpartners
For those wondering if FDA will side w/ #Dacogen panel "FDA Advisory Panels: No Means No, Yes Means Maybe" http://t.co/Kz4mmsOY $ASTX

Feb. 9 at 12:41 PM

from Twitter
MDBpartners
#Dacogen panel voting now... $ASTX

Feb. 9 at 12:32 PM

from Twitter
MDBpartners
Dacogen FDA ODAC meeting webcast link (starts @ 8am ET, sign in as guest - no password req): http://t.co/Ak5Re3xt $ASTX $ESALY $JNJ #biotech

Feb. 9 at 7:44 AM

from Twitter
MDBpartners
Currently reading "Adjuvants: The Heroes of Immunotherapy" article by Drug Discovery News @ http://t.co/GNx0LocM $AGEN #biotech

Feb. 8 at 1:36 PM

from Twitter
MDBpartners
w/ data from nearly a dozen randomized Ph 2/ 3 trials expected, '12 could be breakout yr for cancer immunotherapy http://t.co/nEgsnzjV $DNDN

Feb. 6 at 3:55 PM

from Twitter
MDBpartners
@adamfeuerstein $THLD pancreatic trial very risky due to heterogeneous patient population - discussed at http://t.co/GVrTRixP #biotech

Feb. 3 at 8:18 AM

from Twitter
MDBpartners
Medivation Prostate Cancer Drug Works Well, Appears Safe In Study | Biotech/pharma | http://t.co/MzGhxVla http://t.co/HLvpt1G0 $MDVN $DNDN

Feb. 1 at 9:03 AM

from Twitter
MDBpartners
After Q4 upside surprise, Mitch Gold pulls the George Costanza/Vegas showmanship trick of "walking off" after a high note $DNDN #biotech

Feb. 1 at 7:54 AM

from Twitter
MDBpartners
Dendreon Announces CEO and Chairman Succession Plan - Yahoo! Finance http://t.co/FA0wiHFP $DNDN #biotech

Feb. 1 at 7:50 AM

from Twitter
MDBpartners
$AMGN bid for $MITI would only rank #6 out of 13 monoclonal ab M&A deals from '05 to mid-'10, see Table 2 at http://t.co/QDLoUEgs #biotech

Jan. 31 at 11:49 AM

from Twitter
MDBpartners
$MITI Investor Lawsuit Claims $AMGN $1 Billion Bid Undervalues Shares - Bloomberg http://t.co/vzZbcWMs via @BloombergNews

Jan. 31 at 11:48 AM

from Twitter
MDBpartners
$INFI plunges more than 50% pre-market on failed Ph 2 pancreatic cancer study #biotech

Jan. 27 at 8:14 AM

from Twitter
MDBpartners
$INFI - Pancreatic cancer drug dev has been tough; concerns about $THLD trial rpt next mo due to heterogeneous pt pop @ http://t.co/GVrTRixP

Jan. 27 at 7:51 AM

from Twitter
MDBpartners
RT @adamfeuerstein: $INFI ph 2 study of saridegib in pancreatic cancer fails due to futility. OS favored control arm. #biotech

Jan. 27 at 7:18 AM

from Twitter

Follow investors and traders who match your style.
Interact with a deep investing community.
Journal your ideas - the best investors do!

StockTwits View profile on Twitter

MDBpartners

Join StockTwits Today!

Sign in to StockTwits X

New to StockTwits?

Sign up for real time news, charts, and ideas on the stocks you care about.